I´ve always been interested in the genetic basis for neurological disorders and am looking to apply my background in computational modelling to neuropsychiatry. During my Masters at the University of Bristol, I specialised in computational biology, undertaking a research project in the mechanisms behind Alzheimer's disease. During my undergraduate degree, I did a two month placement at the MRC Biostatistics Unit at the University of Cambridge, looking at risk genes for cancer of the oesophagus in collaboration with a research group at Addenbrookes Hospital. The aim of my PhD is to develop novel statistical techniques to identify reliable molecular biomarkers in autism, schizophrenia and depressive disorders.
I completed my undergraduate degree in Natural Sciences (Neuroscience) at the University of Cambridge. In my final year, I carried out a research project on developing an animal model of OCD at the Department of Psychology, during which I developed an interest in neuropsychiatric disorders. I then became interested in applying -omics approaches to solving biological problems and data analysis during my Masters in Systems Biology. The aim of my PhD is to apply statistical methods to identify proteomic biomarkers, and demographic and clinical factors associated with depression and other affective disorders. The identification of a reproducible set of biomarkers and covariates has the potential to improve diagnosis and predict treatment response in patients.
To be updated ....
Geertje van Rees
I completed a BSc degree in psychobiology at the University of Amsterdam in the Netherlands, as I have always been curious about how the brain is involved in regulating behaviour, disorders and thought processes. Next, I carried out an MSc in Biomedical Sciences with a focus on psychopharmacology and psychopathology at the same university. This involved research internships at the Netherlands Institute of Neuroscience in Amsterdam, the Erasmus Medical Centre in Rotterdam and the Bahn lab at the University of Cambridge in the United Kingdom. During these internships, my studies focussed on the molecular and cellular effects underlying neuropsychiatric disorders such as schizophrenia, with a focus on potential immunological abnormalities. Now, the aim of my PhD project at the University of Cambridge is to identify the involvement of the brain's immune cells, the microglia, in schizophrenia and use this as a potential new drug target.